RECEPTOR BIOLOGIX Trademark

Trademark Overview

On Friday, March 26, 2004, a trademark application was filed for RECEPTOR BIOLOGIX with the United States Patent and Trademark Office. The USPTO has given the RECEPTOR BIOLOGIX trademark a serial number of 78391595. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 7, 2008. This trademark is owned by Receptor BioLogix, Inc.. The RECEPTOR BIOLOGIX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, including pharmaceuticals for the treatment of cancer; pharmaceuticals for the treatment of diabetes; pharmaceuticals for the treatment of insulin resistance syndrome; pharmaceuticals for the treatment of diabetes-associated vascular disease; pharmaceuticals for the treatment of neurodegenerative diseases; pharmaceuticals for the treatment of angiogenesis-related diseases; pharmaceuticals for the treatment of arthritis; pharmaceuticals for the treatment of autoimmune diseases; and pharmaceuticals for the treatment of endometriosis
receptor biologix

General Information

Serial Number78391595
Word MarkRECEPTOR BIOLOGIX
Filing DateFriday, March 26, 2004
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 7, 2008
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 11, 2005

Trademark Statements

Disclaimer with Predetermined Text"BIOLOGICS"
Goods and ServicesPharmaceutical preparations, including pharmaceuticals for the treatment of cancer; pharmaceuticals for the treatment of diabetes; pharmaceuticals for the treatment of insulin resistance syndrome; pharmaceuticals for the treatment of diabetes-associated vascular disease; pharmaceuticals for the treatment of neurodegenerative diseases; pharmaceuticals for the treatment of angiogenesis-related diseases; pharmaceuticals for the treatment of arthritis; pharmaceuticals for the treatment of autoimmune diseases; and pharmaceuticals for the treatment of endometriosis
Pseudo MarkRECEPTOR BIOLOGIC

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 2, 2004
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameReceptor BioLogix, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPalo Alto, CA 94303
Party NameReceptor BioLogix, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressEncinitas, CA 92024

Trademark Events

Event DateEvent Description
Tuesday, June 10, 2008ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Tuesday, June 10, 2008ABANDONMENT - NO USE STATEMENT FILED
Thursday, October 4, 2007EXTENSION 5 GRANTED
Tuesday, September 25, 2007EXTENSION 5 FILED
Tuesday, September 25, 2007TEAS EXTENSION RECEIVED
Thursday, May 10, 2007APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, May 10, 2007TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, March 28, 2007EXTENSION 4 GRANTED
Wednesday, March 28, 2007EXTENSION 4 FILED
Wednesday, March 28, 2007TEAS EXTENSION RECEIVED
Wednesday, November 29, 2006ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 29, 2006TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 2, 2006EXTENSION 3 GRANTED
Monday, October 2, 2006EXTENSION 3 FILED
Monday, October 2, 2006TEAS EXTENSION RECEIVED
Tuesday, April 11, 2006EXTENSION 2 GRANTED
Friday, March 24, 2006EXTENSION 2 FILED
Friday, March 24, 2006TEAS EXTENSION RECEIVED
Tuesday, November 1, 2005TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 1, 2005TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 14, 2005EXTENSION 1 GRANTED
Friday, September 30, 2005EXTENSION 1 FILED
Friday, September 30, 2005TEAS EXTENSION RECEIVED
Tuesday, April 5, 2005NOA MAILED - SOU REQUIRED FROM APPLICANT
Friday, February 18, 2005ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 18, 2005TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, January 31, 2005TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 11, 2005PUBLISHED FOR OPPOSITION
Wednesday, December 22, 2004NOTICE OF PUBLICATION
Friday, November 5, 2004LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, October 29, 2004ASSIGNED TO LIE
Monday, October 25, 2004APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 25, 2004EXAMINERS AMENDMENT E-MAILED
Monday, October 25, 2004EXAMINERS AMENDMENT -WRITTEN
Wednesday, October 13, 2004ASSIGNED TO EXAMINER
Friday, April 2, 2004NEW APPLICATION ENTERED IN TRAM

Related Keywords

biologix receptor treatment pharmaceuticals diseases diabetes angiogenesis neurodegenerative related arthritis endometriosis autoimmune